Dr Jung-i Yang, MD | |
22 Odyssey, Suite 245, Irvine, CA 92618-3186 | |
(949) 552-5108 | |
(949) 552-0284 |
Full Name | Dr Jung-i Yang |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 44 Years |
Location | 22 Odyssey, Irvine, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1255309092 | NPI | - | NPPES |
00A438820 | Medicaid | CA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RI0200X | Internal Medicine - Infectious Disease | A43882 (California) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Hoag Memorial Hospital Presbyterian | Newport beach, CA | Hospital |
Mailing Address | Practice Location Address |
---|---|
Dr Jung-i Yang, MD 22 Odyssey, Suite 245, Irvine, CA 92618-3186 Ph: (949) 552-5108 | Dr Jung-i Yang, MD 22 Odyssey, Suite 245, Irvine, CA 92618-3186 Ph: (949) 552-5108 |
News Archive
A.P. Pharma, Inc., a specialty pharmaceutical company, today reported financial results for its fourth quarter and full year ended December 31, 2010 and provided a corporate update.
A study led by researchers at the Keck School of Medicine of the University of Southern California (USC) and Harvard Medical School has identified seven genetic risk factors DNA sequences carried by some people but not others that predict risk for prostate cancer.
Although the basic outlines of human hearing have been known for years – sensory cells in the inner ear turn sound waves into the electrical signals that the brain understands as sound – the molecular details have remained elusive.
Abbott today announced that the XIENCE Xpedition Everolimus Eluting Coronary Stent System received U.S. Food and Drug Administration (FDA) approval and is launching immediately in the United States, providing physicians with a next-generation technology with the largest size matrix in the U.S. market.
CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, and Cardiogenesis Corporation, a leading developer of surgical products used in the treatment of patients with refractory angina resulting from diffuse coronary artery disease, today announced that the boards of directors of both companies have approved a definitive agreement under which CryoLife will acquire all of the outstanding shares of Cardiogenesis for $0.457 per share.
› Verified 9 days ago
Akbar Nassiry, M.D., M.P.H. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4000 Barranca Parkway, Ste. 250, Irvine, CA 92604 Phone: 949-577-0047 Fax: 909-635-6085 | |
Omid Vesal, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2500 Alton Parkway, Suite 101, Irvine, CA 92606 Phone: 949-222-2722 Fax: 949-222-9969 | |
Dr. Maria Teresa Corpin Agner, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 11 Technology Dr, Irvine, CA 92618 Phone: 855-206-6764 Fax: 949-923-3575 | |
Dr. Susan Davoodifar, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 4199 Campus Dr, Suite 550, Irvine, CA 92612 Phone: 949-509-6503 Fax: 949-326-0103 | |
Randa Serag, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4708 Barranca Pkwy, Irvine, CA 92604 Phone: 949-791-3101 Fax: 949-791-3112 | |
Tara E Seery, Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 16105 Sand Canyon Ave Ste 230, Irvine, CA 92618 Phone: 949-764-5347 Fax: 949-557-0221 | |
Nadir Yusaf Qazi, DO Infectious Disease Medicare: Medicare Enrolled Practice Location: 113 Waterworks Way Ste 105, Irvine, CA 92618 Phone: 949-336-7293 |